Little is still known about the specific mechanism of action of non-coding RNAs (ncRNAs) in stroke, but studies have confirmed that ncRNAs can regulate the pathological process of stroke by controlling processes such as transcription and translation. The overall research on drugs targeting ncRNAs has progressed rapidly, but related research in the field of stroke has been slow, in large part because the role of ncRNAs in stroke is not yet known. To address this issue, Ace Therapeutics offers professional services to accelerate your research exploring the role of ncRNAs in stroke.
It was found that miRNAs can be used as a biomarker of stroke and can be used to identify ischemic stroke and hemorrhagic stroke. However, its specific role in stroke is not yet known. Therefore, Ace Therapeutics offers a series of services to explore the role of miRNAs in stroke.
lncRNAs affect the pathological process of stroke through various pathways such as apoptosis and inflammation. However, the related mechanisms of action are not in-depth, so Ace Therapeutics provides a comprehensive service to explore the role of lncRNAs in stroke.
circRNAs are associated with multiple pathological pathways in the brain during strokes, such as neuronal apoptosis, excitotoxicity, neuroinflammation, and autophagy. However, the specific roles of circRNAs in these processes are not known. Therefore, Ace Therapeutics provides a comprehensive service to explore the role of circRNAs in the pathological processes of stroke.
If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.